Olympic Star Pharmaceutical

Founded in 1998, Olympic Star Pharmaceutical is a bio-pharmaceutical company headquartered in Hong Kong with significant manufacturing and research operations in Shenzhen, China. The company specializes in the research, manufacturing, and international trade of vaccines, blood products, and active pharmaceutical ingredients (APIs), serving as a long-standing appointed supplier to the Hong Kong Government. Its commercial portfolio features a range of essential vaccines, including Meningococcal and Varicella vaccines, as well as critical care biologics like Tenecteplase and various human immunoglobulins. Olympic Star is currently expanding its research focus toward the development of advanced oncology treatments, most notably a therapeutic vaccine for lung cancer. The company maintains an extensive global distribution network spanning over 30 countries across Europe, the Americas, and Asia.